REGENXBIO says patient advocacy is now central to its corporate strategy, with patient and family perspectives feeding into company decision-making. The push is

REGENXBIO says patient advocacy is now central to its corporate strategy, with patient and family perspectives feeding into company decision-making. The push is being shaped by Patient Advocacy Director Jennifer VanHoutan and reinforced alongside internal staff recognition.